Your provider should track not only your weight but also body composition changes, laboratory values, and overall well-being
GLP-1 drugs show how quickly innovation can outpace policy, how cost pressures are resolved through access restrictions, and how deeply entrenched inequities shape who benefits from medical progress
The sample will have been diluted 1:5 at this point
Cullinan J, Pheby DFH, Araja D, Berkis U, Brenna E, de Korwin JD, et al
Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist made by Novo Nordisk used to lower blood sugar in people with type 2 diabetes and also used off-label for weight loss in people with obesity and overweight
This includes both the medication and a titration schedule designed to minimize side effects